{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:25:39Z","timestamp":1747290339201},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T16:12:49Z","timestamp":1504714369000},"page":"e8001","source":"Crossref","is-referenced-by-count":3,"title":["Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1\/PDGFRA fusion gene effectively treated with imatinib"],"prefix":"10.1097","volume":"96","author":[{"given":"Masayo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Toki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Hatayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-41-20210226","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"R2-41-20210226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R3-41-20210226","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allery Clin Immunol"},{"key":"R4-41-20210226","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00062752-200701000-00008","article-title":"Diagnosis and treatment of hypereosinophilic syndroms","volume":"14","author":"Fletcher","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R5-41-20210226","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/nm.2966","article-title":"PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas","volume":"11","author":"Laimer","year":"2012","journal-title":"Nature Medicine"},{"key":"R6-41-20210226","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/leu.2012.304","article-title":"Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma","volume":"27","author":"Turner","year":"2013","journal-title":"Leukemia"},{"key":"R7-41-20210226","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2005.05863.x","article-title":"Multilineage involvement of the fusion gene in patients with FIP1L1\/PDGFRA-positive hypereosinophilic syndrome","volume":"132","author":"Robyn","year":"2005","journal-title":"Br J Haematol"},{"key":"R8-41-20210226","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/1097-0142(20001115)89:10<2138::AID-CNCR15>3.0.CO;2-W","article-title":"Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma","volume":"89","author":"Granel","year":"2000","journal-title":"Cancer"},{"key":"R9-41-20210226","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1067\/mjd.2002.107233","article-title":"Necrotic cutaneous lesions induced by hypereosinophilic syndrome secondary to a T-cell lymphoma","volume":"46","author":"Aractingi","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R10-41-20210226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3904\/kjim.2006.21.1.57","article-title":"Peripheral T-cell lymphoma-unspecified (PTCL-u) presenting with hypereosinophilic syndrome and pleural effusions","volume":"21","author":"Choi","year":"2006","journal-title":"Korean J Intern Med"},{"key":"R11-41-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10428190500275443","article-title":"Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinopilic syndrome to questionable Kimura's disease resulting in parotid mass","volume":"47","author":"Beyazit","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R12-41-20210226","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1365-4632.2007.03190.x","article-title":"Erythrodermic cutaneous T-cell lymphoma with hypereosinophilic syndrome: treatment with interferon alfa and extracorporeal photopheresis","volume":"46","author":"Lee","year":"2007","journal-title":"Int J Dermatol"},{"key":"R13-41-20210226","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4081\/rt.2009.e42","article-title":"Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome","volume":"1","author":"Nozawa","year":"2009","journal-title":"Rare Tumors"},{"key":"R14-41-20210226","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2169\/internalmedicine.50.5936","article-title":"Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) in a patient with hypereosinophilic syndrome showing multiple nodules on chest computed tomography","volume":"50","author":"Kunimasa","year":"2011","journal-title":"Intern Med"},{"key":"R15-41-20210226","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.oooo.2013.03.017","article-title":"Hypereosinophilic syndrome-lymphocytic variant transforming into peripheral T-cell lymphoma with sever oral manifestations","volume":"116","author":"d\u2019Elb\u00e9e","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:32:22Z","timestamp":1620959542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709080-00041"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":15,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008001","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}